HealthEquity EBITDA Margin 2014-2024 | HQY

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for HealthEquity (HQY) over the last 10 years. The current EBITDA margin for HealthEquity as of July 31, 2024 is .
HealthEquity EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-07-31 $1.10B $0.33B 30.03%
2024-04-30 $1.04B $0.29B 27.90%
2024-01-31 $1.00B $0.27B 27.33%
2023-10-31 $0.97B $0.25B 25.75%
2023-07-31 $0.94B $0.23B 24.31%
2023-04-30 $0.90B $0.20B 22.56%
2023-01-31 $0.86B $0.17B 20.07%
2022-10-31 $0.83B $0.13B 15.76%
2022-07-31 $0.80B $0.12B 14.84%
2022-04-30 $0.78B $0.11B 14.40%
2022-01-31 $0.76B $0.12B 15.34%
2021-10-31 $0.74B $0.13B 18.08%
2021-07-31 $0.74B $0.14B 19.19%
2021-04-30 $0.73B $0.15B 20.36%
2021-01-31 $0.73B $0.16B 21.15%
2020-10-31 $0.75B $0.17B 22.52%
2020-07-31 $0.72B $0.16B 21.55%
2020-04-30 $0.64B $0.15B 23.15%
2020-01-31 $0.53B $0.14B 25.38%
2019-10-31 $0.41B $0.11B 27.76%
2019-07-31 $0.32B $0.11B 33.44%
2019-04-30 $0.30B $0.10B 33.88%
2019-01-31 $0.29B $0.10B 33.45%
2018-10-31 $0.27B $0.09B 32.47%
2018-07-31 $0.26B $0.08B 31.78%
2018-04-30 $0.24B $0.08B 31.15%
2018-01-31 $0.23B $0.07B 30.57%
2017-10-31 $0.22B $0.07B 31.02%
2017-07-31 $0.20B $0.06B 30.20%
2017-04-30 $0.19B $0.06B 30.16%
2017-01-31 $0.18B $0.05B 30.34%
2016-10-31 $0.17B $0.05B 30.54%
2016-07-31 $0.16B $0.05B 30.32%
2016-04-30 $0.14B $0.04B 28.37%
2016-01-31 $0.13B $0.03B 26.77%
2015-10-31 $0.12B $0.03B 26.72%
2015-07-31 $0.11B $0.03B 27.10%
2015-04-30 $0.10B $0.03B 26.53%
2015-01-31 $0.09B $0.02B 26.14%
2014-07-31 $0.06B $0.02B 32.14%
2014-04-30 $0.05B $0.02B 32.00%
Sector Industry Market Cap Revenue
Medical Medical Services $7.792B $1.000B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00